Cognitive impairment in substance abuse

Psychiatric Clinics of North America

Volumn 27, Issue 1, 2004, Pages 97-109

  Vik, Peter W ^a   Cellucci, Tony ^a   Jarchow, Amy ^a   Hedt, Jill ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ALCOHOL CONSUMPTION; BRAIN GROWTH; COGNITION; COGNITIVE DEFECT; DETOXIFICATION; DRUG DEPENDENCE; DRUG EXPOSURE; HUMAN; INTOXICATION; KORSAKOFF PSYCHOSIS; MEDICAL LITERATURE; MEDICAL RESEARCH; MULTIPLE DRUG ABUSE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RATING SCALE; REVIEW; SUBSTANCE ABUSE; THEORETICAL STUDY;

ALCOHOL AMNESTIC DISORDER; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 1642363895     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00110-2     Document Type: Review

References (59)

1. Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol 2002;10:193-212.
2. Julien RM. A primer of drug action. New York: Worth Publishers; 2000.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. 4th edition, technical revision. Washington (DC): American Psychiatric Association; 2000.
4. Kuhn C, Swartzwelder S, Wilson W. Buzzed: the straight facts about the most used and abused drugs from alcohol to ecstasy. New York: WW Norton and Company; 1998.
5. Fals-Stewart W, Schafer J, Lucente S, Rustine T, Brown L. Neurobehavioral consequences of prolonged alcohol and substance abuse: a review of findings and treatment implications. Clin Psychol Rev 1994;14:775-88.
6. Rourke SB, Lørberg T. The neurobehavioral correlates of alcoholism. In: Grant I, Adams KM, editors. Neuropsychological assessment of neuropsychiatric disorders. 2nd edition. New York: Guilford; 1998. p. 423-85.
7. Allen DN, Landis RKB. Neuropsychological correlates of substance use disorders. In: Snyder PJ, Nussbaum PD, editors. Clinical neuropsychology: a pocket handbook for assessment. Washington (DC): American Psychological Association; 1998. p. 591-612.
8. Goldman MS. Experience-dependent neuropsychological recovery and the treatment of chronic alcoholism. Neuropsychological Review 1990;1:75-101.
9. Butters N, Salmon DP, Cullum CM, Cairns P. Differentiation of amnesic and demented patients with the Wechsler Memory Scale-Revised. Clin Neuropsychol 1988;2:133-48.
10. Heindel WC, Salmon DP. Cognitive approaches to the memory disorders of demented patients. In: Sutker PB, Adams HE, editors. Comprehensive handbook of psychopathology. 3rd edition. New York: Kluwer Academic/Plenum Publishers; 2001. p. 841-78.
11. Pope HG, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38(1):25-34.
12. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275(7):521-7.
13. Block RI. Does heavy marijuana use impair human cognition and brain function? JAMA 1996;275(7):560-1.
14. Carlin AS, O'Malley S. (1998). Neuropsychological consequences of drug abuse. In: Grant I, Adams KM, editors. Neuropsychological assessment of neuropsychiatric disorders. 2nd edition. New York: Guilford; 1998. p. 486-503.
15. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 1986;43:107-13.
16. Weaver MF, Schnoll SH. Stimulants: amphetamines and cocaine. In: McCrady BS, Epstein EE, editors. Addictions: a comprehensive guidebook. London: Oxford University Press; 1999. p. 105-20.
17. McKetin R, Mattick RP. Attention and memory in illicit amphetamine users: comparison with nondrug-using controls. Drug Alcohol Depend 1998;50:181-4.
18. McKetin R, Mattick RP. Attention and memory in illicit amphetamine users. Drug Alcohol Depend 1997;48:235-42.
19. Volkow N, Chang L, Wang G, Fowler JS, Leonido-Yee M, Franceschi D, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001;158:377-82.
20. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research. Neuroimaging 2002;114:65-79.
21. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 2000;9:222-31.
22. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway, et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine- dependent individuals. Psychiatry Res 2002;111:65-74.
23. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetaminedependent subjects. Neuropsychopharmacology 2002;26:53-63.
24. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 2003;53:65-74.
25. Peroutka SJ, Newman H, Harris H. Subjective effects of 3, 4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1988;1:273-8.
26. Saunders N. Ecstasy and the drug culture. London: Nicholas Saunders; 1995.
27. Parrott AC, Stuart M. Ecstasy (MDMA), amphetamine and LSD: comparative mood profiles in recreational polydrug users. Hum Psychopharmacol 1997;12:501-4.
28. Curran HV, Travill RA. Mood and cognitive effects of 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy): weekend high followed by mid-week low. Addiction 1997;92:821-31.
29. Parrott AC, Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 1998;139:261-8.
30. Green RA, Cross AJ, Goodwin GM. Review of pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA or ecstasy). Pharmacology 1995;119:247-60.
31. McCann UD, Szabo Z, Scheffel U, Matthews WB, Dannals RF, Ravert HT, et al. Positron emission tomographic evidence of toxic effect of MDMA (ecstasy) on brain serotonin neurons in human beings. Lancet 1998;352:1433-7.
32. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA. Cognitive performance in 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) users: a controlled study. Psychopharmacology (Berl) 1999;143:417-25.
33. McCann UD, Ridennour A, Shaham Y, Ricaurte GA. Serotonin neurotoxicity after 3, 4-methylenediaxymethamphetamine (MDMA, ecstasy): a controlled study in humans. Neuropsychopharmacology 1994;10:129-38.
34. Morgan MJ. Recreational use of ecstasy (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998;19(4):252-64.
35. Strassman RJ. Hallucinogenic drugs in psychiatric research and treatment. J Nerv Ment Dis 1995;183:127-38.
36. Halpern JH, Pobe HG. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend 1999;53:247-56.
37. McGee R. Flashbacks and memory phenomena: a comment on flashback phenomena - clinical and diagnostic dilemmas. Journal of Nervous and Mental Disorders 1984;172:273-8.
38. Edwards AE, Bloom MH, Cohen S. The psychedelics: love ore hostility potion. Psychol Rep 1969;24:843-6.
39. Wright M, Hogan TP. Repeated LSD ingestion and performance on neuropsychological tests. Journal of Nervous and Mental Disorders 1972;154:432-8.
40. McGlothlin WH, Arnold DO. Organicity measures following repeated LSD ingestion. Arch Gen Psychiatry 1969;21:704-9.
41. Matefy RE, Hayes C, Hirsch J. Psychedelic drug flashbacks: attentional deficits? J Abnorm Psychol 1979;88:212-5.
42. Grant I, Judd LL. Neuropsychological and EEG disturbances in polydrug users. Am J Psychiatry 1976;133:1039-42.
43. Grant I, Adams KM, Carlin AS, Rennick PM, Judd LL, Schoof K. The collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry 1978;35:1063-74.
44. Fals-Stewart W, Bates ME. The neuropsychological test performance of drug-abusing patients: an examination of latent cognitive abilities and associated risk factors. Exp Clin Psychopharmacol 2003;11:34-45.
45. Karan LD, Haller DL, Schnoll SH. Cocaine and stimulants. In: Frances RJ, Miller SI, editors. Clinical textbook of addictive disorders. 2nd edition. New York: Guilford Press; 1998. p. 168-201.
46. Blume SB. Addictive disorders in women. In: Frances RJ, Miller SI, editors. Clinical textbook of addictive disorders. 2nd edition. New York: The Guilford Press; 1998. p. 413-29.
47. Bandstra ES, Morrow CE, Vogel AL, Fifer RC, Ofir AY, Dausa AT, et al. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol 2002;24:297-308.
48. Moss HB, Kirisci L, Gordon HW, Tarter RE. A neuropsychologic profile of adolescent alcoholics. Alcohol Clin Exp Res 1994;18:159-63.
49. Tarter RE, Mezzich AC, Hsieh YC, Parks SM. Cognitive capacity in female adolescent substance abusers. Drug Alcohol Depend 1995;39:15-21.
50. Tapert SF, Brown SA. Neuropsychological correlates of adolescent substance abuse: 4-year outcomes. J Int Neuropsychol Soc 1999;5:481-93.
51. Brown SA, Tapert SF, Granholm E, Delis DC. Neurocognitive functioning of adolescents: effects of protracted alcohol use. Alcohol Clin Exp Res 2000;24:164-71.
52. Tapert SF, Granholm E, Leedy NG, Brown SA. Substance use and withdrawal: neuropsychological functioning over 8 years in youth. J Int Neuropsychol Soc 2002;8:873-83.
53. Allen DN, Goldstein G, Seaton BE. Cognitive rehabilitation and chronic alcohol abusers. Neuropsychol Rev 1999;7:21-39.
54. Miller WR, Rollnick S. Motivational interviewing. 2nd edition. New York: Guilford Press; 2002.
55. Rychtarik RG, Connors GJ, Whitney RB, McGillicuddy NB, Fitterling JM, Wirtz PW. Treatment settings for persons with alcoholism: evidence for matching clients to inpatient versus outpatient care. J Consult Clin Psychol 2000;68:277-89.
56. Kadden R, Cooney N, Getter H, Litt M. Matching alcoholics to coping skills or interactional therapies: post-treatment results. J Consult Clin Psychol 1985;57:698-704.
57. McCrady BS, Smith DE. Implications of cognitive impairment for the treatment of alcoholism. Alcohol Clin Exp Res 1986;10:145-9.
58. Fals-Stewart W, Lucente S. The effect of cognitive rehabilitation on the neuropsychological status of patients in drug abuse treatment who display neurocognitive impairment. Rehabil Psychol 1994;39:75-94.
59. Peterson MA, Patterson B, Pillman BM, Battista MA. Cognitive recovery following alcohol detoxification: a computerized remediation study. Neuropsychological Rehabilitation 2002;12:62-74.